Search Images Maps Play YouTube News Gmail Drive More »
Settings | Sign in

Clostridium difficile

VALNEVA Announces Successful Completion of Phase II for Clostridium Difficile Vaccine Candidate

GlobeNewswire (press release) - ‎Jul 25, 2016‎
Thomas Lingelbach, President and CEO, and Franck Grimaud, Deputy CEO of Valneva, commented, "We are pleased with the positive final data generated in this Phase II trial and believe that our C. difficile candidate has the potential to address a growing ...

FDA grants QIDP for C. Difficile IV treatment

European Pharmaceutical Review - ‎Jul 25, 2016‎
Morphochem announced today that the U.S. Food and Drug Administration (FDA) has designated Morphochem's intravenous antibacterial product candidate MCB3837 as a qualified infectious disease product (QIDP) for the treatment of Clostridium difficile ...
See realtime coverage

FDA Delays Decision on Merck C. difficile Candidate, Seeks More Data

Genetic Engineering & Biotechnology News - ‎Jul 22, 2016‎
Merck & Co. said the FDA has delayed to October a decision on its application to market bezlotoxumab for the prevention of Clostridium difficile infection recurrence, after requesting more clinical data from the company. In a statement late yesterday ...

2016 Global Clostridium difficile Partnering Market Research

NewsMaker (press release) - ‎Jul 21, 2016‎ adds 'Global Clostridium difficile Partnering 2010 to 2016' Market Research to its database, providing in-depth, high quality, transparent and market-driven, expert's analysis.

Clostridium difficile Infection (CDI) Therapeutics Market Research Report Now Available at Research Corridor

The Republic of East Vancouver - ‎Jul 21, 2016‎
Research Corridor has published a new research study titled “Clostridium difficile Infection (CDI) Therapeutics Market - Growth, Share, Opportunities, Competitive Analysis and Forecast, 2015 - 2022”.

Clostridium difficile Infection (CDI) Therapeutic Market Research Report Now Available at Research Corridor

The Republic of East Vancouver - ‎Jul 14, 2016‎
Research Corridor has published a new research study titled “Clostridium difficile Infection (CDI) Therapeutic Market - Growth, Share, Opportunities, Competitive Analysis and Forecast, 2015 - 2022”.

FDA delays decision on Merck's C. diff drug

BioPharma Dive - ‎Jul 25, 2016‎
The Food and Drug Administration requested additional trial data and analysis for Merck's investigational monoclonal antibody, bezlotoxumab, which is in development for secondary prevention of Clostridium difficile (C. diff), the company reported Thursday.

Study tracing ancestor microorganisms suggests life started in a hydrothermal environment

The Conversation UK - ‎Jul 25, 2016‎
Scanning electron micrograph of Clostridium difficile bacteria from a stool sample. CDC/ Lois S. Wiggs/wikimedia. The result is important because it identifies specific groups of bacteria (clostridia) and archaea (methanogens) that carry early versions ...
See realtime coverage

VALNEVA : nouveaux résultats positifs pour son candidat vaccin contre le Clostridium difficile

Le Figaro - ‎Jul 25, 2016‎
(AOF) - Valneva a annoncé des résultats de fin de Phase II positifs pour son candidat vaccin prophylactique VLA84 visant la prévention primaire des infections au Clostridium difficile (CDI), actuellement l'une des principales causes mondiales d ...

FDA Grants QIDP And Fast Track Designations To MCB3837 ...

Clinical Leader - ‎8 hours ago‎
Munich, Germany / B3C newswire / - Morphochem, a clinical-stage pharmaceutical company, announced today that the U.S. Food and Drug Administration ...

WATCH: See how a superbug is created

STAT - ‎6 hours ago‎
How do some bugs gain resistance to multiple antibiotics, becoming superbugs? STAT explains.

Does PPI Use Up Rate of Hospital-Acquired C. diff Infection?

Monthly Prescribing Reference (registration) - ‎22 hours ago‎
The use of proton pump inhibitors (PPIs) was associated with an increase in both the rate and severity of hospital-acquired Clostridium difficile infection (CDI), according to a study published in Pharmacotherapy. Study authors performed a ...

Global Clostridium Difficile Partnering 2010 to 2016; New Report Launched

Digital Journal - ‎Jul 18, 2016‎
Bangalore, Karnataka -- (SBWIRE) -- 07/18/2016 -- Provides understanding and access to the clostridium difficile partnering deals and agreements entered into by the worlds leading healthcare companies.

Schneck Medical Center Implements the Power of Ultraviolet Technology against Hospital Infections

PR Newswire (press release) - ‎2 hours ago‎
"Cleaning and disinfection plays a crucial role in infection prevention and with germs such as C. diff able to survive on surfaces for months at a time, we felt it was important to implement even more comprehensive cleaning procedures as part of our ...

Betsi Cadwaladr 'improvements' after C. diff outbreak

BBC News - ‎Jul 17, 2016‎
"Very significant improvements" have been made at a health board following the outbreak of a major infection three years ago.

Clostridium Difficile, slitta la registrazione Usa di bezlotoxumab

PharmaStar - ‎Jul 24, 2016‎
Clostridium Difficile, slitta la registrazione Usa di bezlotoxumab. L'Fda ha richiesto nuovi dati e nuove analisi degli studi MODIFY I e MODIFY II per poter prendere una decisione circa l'approvazione di bezlotoxumab, un nuovo anticorpo monoclonale ...

The Peoples Pharmacy: Poop transplants are catching on

Roanoke Times (blog) - ‎22 hours ago‎
People who receive certain broad-spectrum antibiotics such as clindamycin (Cleocin) sometimes end up with life-threatening diarrhea brought on by bacterial overgrowth from Clostridium difficile. The resulting C. diff colitis can be very hard to treat.
See realtime coverage

Poo transplants transfer much more than bacteria

Cosmos - ‎Jul 12, 2016‎
For instance, around 95% of people suffering Clostridium difficile, a bacterium that infects the bowel causing diarrhoea, treated with faecal transplants are cured.

Poo Can Save Lives Thanks to New Fecal Transplant - ‎Jul 18, 2016‎
Fecal transplantation sounds gross and it's not something most of us want to talk about. But if you have a form of colitis called Clostridium difficile, someone else's fecal matter may cure what ails you. “There is no doubt that poo can save lives ...

Autism and the Microbiome: Will Fecal Transplants Be the Next “AWAKENINGS?" Part 2

Age of Autism - ‎Jul 25, 2016‎
Fecal microbiota transplantation (FMT), a unique method to reestablish a sustained balance in the disrupted microbiota of diseased intestine, has demonstrated great success in the treatment of recurrent Clostridium difficile infection and has gained ...